Efeito do tratamento com fatores hepatotróficos em ratas (Wistar) induzidas experimentalmente à cirrose por Tioacetamida [thesis]

Ricardo Romão Guerra
remodelação da matriz extracelular hepática em fígados cirróticos pela diminuição da expressão de genes fibrogênicos e não necessariamente pelo aumento da expressão de genes fibrolíticos. Ademais, animais cirróticos apresentaram em seu fígado e intestino progranulina, um novo fator de crescimento. Propomos, dessa forma, a utilizalção da progranulina como um possível marcador clínico e alvo terapêutico para doenças hepáticas. Palavras -chave: Cirrrose. Tioacetamida. Fatores hepatotróficos.
more » ... ção da matriz extracelular. Progranulina. ABSTRACT GUERRA, R. R. Effect of hepatotrophic factors on thioacetamide-induced cirrhosis in rats. [Efeito do tratamento com fatores hepatotróficos em ratas (Wistar) induzidas experimentalmente à cirrose por Tioacetamida]. 2006. 185 f. Tese (Doutorado em Ciências) -Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, 2006. Cirrhosis is characterized by fibrosis and regenerative nodules, which result in the disorganization of the hepatic architecture, being considered an irreversible situation. The administration of exogenous hepatotrophic factors (EHF) could stimulate hepatic regeneration in hepatocytes cells and reduce the cirrhosis induced in rats. The aim of this work was to evaluate the effect of EHF in rat cirrhosis induced experimentally by thioacetamide. It was carried out histopathologics analysis; BrdU imunoperoxidase, collagen measurement, scanning electron microscopy; biochemical analysis for hepatic function and analysis on genic expression for collagen α1, TGFβ 1, TIMP I, MMP 2, and Plau by real time PCR. After the EHF administration, it was observed a reduction in the expression of fibrogenics genes as: collagenα1, TGFβ1, TIMP I and MMP 2. During the extracellular matrix (ECM) remodelation morphofuntional improvements were observed, with decrease of regenerative nodules and fibrous septs thickness as well as reappearance of central vein. It was observed increase in liver weight, volume and in the relation liver/carcass. The animals treated with EHF had a reduction of 29.62% in the total collagen when compared with their own biopsy before treatment, while the non-treated animals had an increase of 8,7%. The index of hepatic functions had significant improvement in the levels of gamaglutamiltranspeptida (GGT), alanine aminotransferase and aspartate aminotransferase. Therefore, the EHF acts on the extracellular matrix remodelation though reduction of fibrogenics gene expression and not necessarily by fibrolitics genes expression increase. In addiction, we have found progranulin, a new growth factor, in liver and intestine of cirrhotic animals. Hence, we propose the utilization of progranulin as a clinical marker and a therapeutic target for hepatic deseases.
doi:10.11606/t.10.2006.tde-06032007-110538 fatcat:7x6kzyoveff4zpba3uwccc23ja